...Going uP!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DMAN AS 460,000,000
12/06/2019
OS 431,424,670
12/06/2019
Otcmarkets.com
Pushing Oil & Gas Technology Forward - GeoEnhanced Technologies
As per new update, no AS increase. - There will be no RS.
Thank you DMAN "no AS increase. - There will be no RS. Happy Holidays!"
$BooM BooM$ DMAN
DMAN UPDATE!
GeoEnhanced Technologies
@geoenhanced
We currently have several deals on the table and are working hard on all ends. 2019 was a great new beginning for $DMAN and its shareholders. As we prepare for 2020 I would like to highlight a couple points; - At this time no AS increase. - There will be no RS. Happy Holidays!
11:40 AM · Dec 27, 2019
Twitter
I agree! DMAN$$$$
UPDATE!! GeoEnhanced Technologies
@geoenhanced
We currently have several deals on the table and are working hard on all ends. 2019 was a great new beginning for $DMAN and its shareholders. As we prepare for 2020 I would like to highlight a couple points; - At this time no AS increase. - There will be no RS. Happy Holidays!
11:40 AM · Dec 27, 2019
$$ There is a Higher DMAN for DMAN $$ imo $$$$ oil 2020 q2-3 here we come. $$$$$$$
DMAN. News!!!! $$$$$$$ we have an estimated timeline to look forward to.. some cha-ching is coming imo.. glad ive been loading for the end of 2Q 2020..
Good luck to all DMAN
Its coming!!!!!! Loading more
Happy Holidays DMAN
yep! Here's the Link :
https://backend.otcmarkets.com/otcapi/company/dns/news/document/38910/content
Form 4
DMAN $$$$
DMAN from 002 to 02 imo history repeats itself. CEO purchased 5mil shares ranging mid 002s to high 004s
Lots of potential here LOTS. Enjoy the ridee
Good luck all!
Good Morning DMAN !!
CTST BOOM!! $$$$
PStat in the houuse! Go CTST $$
CTST holding on strong with the recent news imo. So far so good $$$$$
CTST has a ton of potential at these levels IMO $2 range not far at all. Glta
5 mil traded so far DMAN
CTST $$$$$ Looking forward to todays action
Shea moving UP! CTST
Loaded more here ACNV
ACNV if true then $$$$ is coming imo
Wow L2 is thin going up imo gl to all
ACNV $$$$ my shares are $$$$ what is going on here!!?
JAGX hits low, Time to buy?
DMAN ringing the alarms today $$$$$ pretty interesting news ... locked and loaded
DMAN. $$$$
Locked and loaded KALY
KALY is rocking today
KALY is movvvvinngggg $$$$$$$$
KALY had a good run today. Watching tomorrow
Hellllo KALY Interesting News. $$$$
KALY – KALI-EXTRACTS CONFIRMS CANNABIS BIOPHARMACEUTICAL UPDATE TARGETING $170 BILLION MARKET SCHEDULED FOR RELEASE TOMORROW
Posted August 19, 2019
In Newsroom
Dallas, TX – Aug 19, 2019 — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled CEO update to be published tomorrow on Tuesday, August 20th, 2019 to provide shareholders with the latest updates on the company’s Cannabis Extract Biopharmaceutical developments. The company is currently developing Cannabis Extract Biopharmaceutical Therapies targeting $170 billion in market potential:
Chronic Obstructive Pulmonary Disease (COPD) – The market for COPD treatment is anticipated to reach $14 billion by 2025;
Type 2 Diabetes – The market for Type 2 Diabetes is expected to be a $64 billion market by 2026;
Cancer Pain Management – The overall pain management treatment market is anticipated to reach $83 billion by 2024, and
Epilepsy – The market for epilepsy treatment is anticipated to reach $9 billion by 2022.
KALY has recently made a substantial step forward in its Cannabis Extract Biopharmaceutical developments which will be featured tomorrow in the CEO update.
KALY owns and operates a US Patented Cannabis Extraction Process utilized primarily on discovering, developing and commercializing novel therapeutics from a proprietary cannabinoid product platform in a broad range of disease areas. In the fourth quarter of last year, 2018, KALY acquired NCM Biotech (NCMB). In NCMB’s four years of operations, the company has established a leading position in the development of plant-derived cannabinoid therapeutics through a proven drug discovery and patented development process. The resulting intellectual property portfolio and the established regulatory and manufacturing expertise have created a significant opportunity. KALY has a deep pipeline of cannabinoid product candidates including four distinct compounds. KALY has completed the first stage of clinical development and testing for a Chronic Obstructive Pulmonary Disease (COPD) therapy and is currently conducting phase one development and trials for compounds targeting Cancer Pain Management, Type 2 Diabetes and Epilepsy. Next week, CEO Frederick Ferri will share the latest developments on the company’s biopharmaceutical developments.
KALY is not relying on its biopharmaceutical development strategy alone to insure the company’s long-term success. With the popularity of cannabis extracts for infusion into various consumer products, KALY’s patented extraction process offers arguably the highest quality extract to the infusion market. KALY, through partnership and independently, has also introduced to market a number of CBD infused consumer food products. Drawing on KALY’s patented cannabis extraction expertise, the company has recently announced $15 million worth of extraction contracts with hemp farming operations.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company’s actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214) 210-0459
Well said. GO DMAN $$$$$$
DMAN history shows we are due a Q soon.. $DMAN
Good observation on the DMAN chart Looking forward to new highs $$$$$$$
ACB it would be nice
Good Morning DMAN!!
Go DMAN BOUNCE UP! Looking good today $ Tomorrow maybe interesting imo $$$$$$$
LTNC over 400mil traded $$$